References
- Fiala C, Gemzell-Danielson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006;74:66–86.
- Raymond EG, Shannon C, Weaver MA. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception 2013;87:26–37.
- Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception 2016;94:97–103.
- Fiala C, Safar P, Bygdeman M, et al. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol. 2003;109:190–195.
- International Federation of Gynecology and Obstetrics. Misoprostol-only recommended regimens 2017. [cited 2018 Jan 9]. Available from: www.figo.org/sites/default/files/uploads/project-publications/Miso/FIGO_Dosage_Chart%20EN_0.pdf.
- Khan K. The CROWN initiative: journal editors invite researchers to develop core outcomes in women’s health. J Ovarian Res 2015;8:6.
- Whitehouse KC, Kim CR, Ganatra B, et al. Standardizing abortion research outcomes (STAR): a protocol for developing, disseminating and implementing a core outcome set for medical and surgical abortion. Contraception. 2017;95:437–441.
- World Health Organization. Managing incomplete abortion. Education material for teachers of midwifery. Midwifery education modules. 2nd ed. Geneva: WHO; 2008.
- World Health Organization. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: WHO; 2012.
- World Health Organization. Clinical practice handbook for safe abortion. Geneva: WHO; 2014.
- International Planned Parenthood Federation. First trimester abortion guidelines and protocols. Surgical and medical procedures. 2008 [cited 2017 Nov 29]. Available from: www.ippf.org/resource/First-Trimester-Abortion-Guidelines-and-Protocols.
- FIGO Working Group on Prevention of Unsafe Abortion and its Consequences; International Federation of Gynecology and Obstetrics. The combination of mifepristone and misoprostol for the termination of pregnancy. Int J Gynaecol Obstet. 2011;115:1–4.
- Gynuity Health Projects. Medical abortion guidebook. 2009 [cited 2017 Nov 29]. Available from: http://gynuity.org/resources/info/medical-abortion-guidebook.
- Haute Autorité de Santé. Interruption volontaire de grossesse par méthode médicamenteuse. Recommandations. 2010 [cited 2017 Nov 29]. Available from: www.has-sante.fr/portail/upload/docs/application/pdf/2011-04/ivg_methode_medicamenteuse_-_argumentaire_-_mel_2011-04-28_11-39-33_198.pdf.
- Haute Autorité de Santé. Interruption volontaire de grossesse par méthode médicamenteuse. Argumentaire. 2010 [cited 2017 Nov 29]. Available from: www.has-sante.fr/portail/upload/docs/application/pdf/2011-04/ivg_methode_medicamenteuse_-_recommandations_-_mel_2011-04-28_11-39-11_882.pdf.
- Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence-based clinical guideline number 7. 2011 [cited 2017 Nov 29]. Available from: www.rcog.org.uk/globalassets/documents/guidelines/abortion-guideline_web_1.pdf.
- Royal College of Obstetricians and Gynaecologists. Best practice in comprehensive abortion care. Best practice paper no. 2. 2015 [cited 2017 Nov 29]. Available from: www.rcog.org.uk/globalassets/documents/guidelines/best-practice-papers/best-practice-paper-2.pdf.
- Work and Reference Group for Family Planning, Swedish Society of Obstetrics and Gynaecology. Induced abortion. Guideline no. 78 [in Swedish]. 2018 [2018 Oct 4]. Available from: www.sfog.se/natupplaga/ARGrappor9792c7d5-5648-475e-bee6-81478b0d9323.pdf.
- Tang J, Kapp N, Dragoman M, et al. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet. 2013;121:186–189.
- Kapp N, Whyte P, Tang J, et al. A review of evidence for safe abortion care. Contraception. 2013;88:350–363.
- Tang OS, Schweer H, Lee SWH, et al. Pharmacokinetics of repeated doses of misoprostol. Hum Reprod. 2009;24:1862–1869.
- Gomperts R, Petow S, Jelinska K, et al. Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine. Acta Obstet Gynecol Scand. 2012;91:226–231.
- Raymond EG, Shochet T, Blum J, et al. Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis. Contraception 2017;95:442–448.
- Cameron ST, Glasier A, Johnstone A, et al. Can women determine the success of early medical termination of pregnancy themselves? Contraception. 2015;91:6–11.
- Oppegaard KS, Qvigstad E, Fiala C, et al. Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicenter, non-inferiority, randomized, controlled trial. Lancet. 2015;385:698–704.
- Lièvre M, Sitruk-Ware R. Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy. Contraception. 2009;80:95–100.
- Laifer-Narin SL, Kwak E, Kim H, et al. Multimodality imaging of the postpartum or posttermination uterus: evaluation using ultrasound, computed tomography and magnetic resonance imaging. Curr Probl Diagn Radiol. 2014;43:374–385.
- Acharya G, Haugen M, Brathen A, et al. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting. Acta Obstet Gynecol Scand. 2004;83:390–394.
- Kaneshiro B, Edelman A, Sneeringer RK, et al. Expanding medical abortion: can medical abortion be effectively provided without the routine use of ultrasound. Contraception. 2011;83:194–201.
- Kulier R, Kapp N, Gülmezoglu AM, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011;11:CD002855.
- Schreiber CA, Sober S, Ratcliffe S, et al. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84:230–233.
- Saccone G, Perriera L, Berghella V. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214:572–591.
- Woolner A, Bhattacharya S, Bhattacharya S. The effect of method and gestational age at termination of pregnancy on future obstetric and perinatal outcomes: a register-based cohort study in Aberdeen, Scotland. BJOG. 2014;121:308–318.